Progress in application of terahertz time-domain spectroscopy for pharmaceutical analyses.
biological drugs
chemical drugs
pharmaceutical analysis
progress in application
terahertz time-domain spectroscopy
traditional Chinese medicine
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
05
2023
accepted:
12
06
2023
medline:
3
8
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Terahertz time-domain spectroscopy is an analytical method using terahertz time-domain pulses to study the physical and chemical properties of substances. It has strong potential for application in pharmaceutical analyses as an original non-destructive, efficient and convenient technology for spectral detection. This review briefly introduces the working principle of terahertz time-domain spectroscopy technology, focuses on the research achievements of this technology in analyses of chemical drugs, traditional Chinese medicine and biological drugs in the past decade. We also reveal the scientific feasibility of practical application of terahertz time-domain spectroscopy for pharmaceutical detection. Finally, we discuss the problems in practical application of terahertz time-domain spectroscopy technology, and the prospect of further development of this technology in pharmaceutical analyses. We hope that this review can provide a reference for application of terahertz time-domain spectroscopy technology in pharmaceutical analyses in the future.
Identifiants
pubmed: 37533693
doi: 10.3389/fbioe.2023.1219042
pii: 1219042
pmc: PMC10393043
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1219042Informations de copyright
Copyright © 2023 Huang, Deng, Wei and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Appl Spectrosc. 2013 Nov;67(11):1264-9
pubmed: 24160877
Analyst. 2021 Jun 14;146(12):3888-3898
pubmed: 34042921
Biochem Biophys Res Commun. 2020 Oct 20;531(3):364-371
pubmed: 32800546
Spectrochim Acta A Mol Biomol Spectrosc. 2018 May 5;196:49-57
pubmed: 29428896
Transl Oncol. 2013 Apr;6(2):92-8
pubmed: 23544162
Nat Mater. 2007 Mar;6(3):206-9
pubmed: 17322867
Eur J Med Chem. 2010 Aug;45(8):3293-8
pubmed: 20451306
Molecules. 2018 Jul 02;23(7):
pubmed: 30004436
Int J Pharm. 2011 Oct 31;419(1-2):1-11
pubmed: 21827842
Phys Med Biol. 2002 Nov 7;47(21):3853-63
pubmed: 12452577
Guang Pu Xue Yu Guang Pu Fen Xi. 2016 Dec;36(12):3870-4
pubmed: 30235402
J Phys Chem A. 2014 Nov 20;118(46):10927-33
pubmed: 25386785
Nat Med. 2011 Jan;17(1):130-4
pubmed: 21170048
J Phys Chem A. 2013 Oct 10;117(40):10504-12
pubmed: 24040840
J Phys Chem A. 2012 Aug 2;116(30):8051-7
pubmed: 22784643
J Control Release. 2021 Apr 10;332:367-389
pubmed: 33652114
Mol Biosyst. 2016 Apr;12(4):1082-9
pubmed: 26888073
Sensors (Basel). 2020 Jan 28;20(3):
pubmed: 32012901
Anal Chem. 2023 Jan 17;95(2):1123-1131
pubmed: 36524836
Guang Pu Xue Yu Guang Pu Fen Xi. 2016 Feb;36(2):316-21
pubmed: 27209722
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2015 Aug;71(Pt 4):437-46
pubmed: 26208624
Chem Commun (Camb). 2014 Feb 7;50(10):1181-4
pubmed: 24326969
J Am Chem Soc. 2013 Apr 17;135(15):5828-38
pubmed: 23510511
Curr Opin Gastroenterol. 2007 Mar;23(2):164-70
pubmed: 17268245
Med J Aust. 1950 Aug 12;2(7):261-2
pubmed: 14779554
Opt Lett. 2003 Nov 1;28(21):2058-60
pubmed: 14587814
Trends Biotechnol. 2016 Oct;34(10):810-824
pubmed: 27207226
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Feb 5;266:120470
pubmed: 34649122
Opt Lett. 1989 Oct 15;14(20):1128-30
pubmed: 19753077
Mol Pharm. 2015 Mar 2;12(3):810-5
pubmed: 25615410
Food Sci Nutr. 2020 Feb 27;8(4):1828-1836
pubmed: 32328248
Int J Pharm. 2022 May 25;620:121759
pubmed: 35460849
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Sep 5;258:119825
pubmed: 33901947
J Am Med Assoc. 1958 Jul 19;167(12):1455-9
pubmed: 13563129
Guang Pu Xue Yu Guang Pu Fen Xi. 2013 May;33(5):1220-5
pubmed: 23905323
Chemphyschem. 2007 Sep 17;8(13):1924-7
pubmed: 17647253
Acta Radiol. 2010 Apr;51(3):316-25
pubmed: 20092374
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Feb 5;246:119044
pubmed: 33068898
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Mar 15;229:117948
pubmed: 31887681
Int J Pharm. 2010 Aug 30;396(1-2):91-8
pubmed: 20558265
J Enzyme Inhib Med Chem. 2006 Apr;21(2):241-7
pubmed: 16789440
Guang Pu Xue Yu Guang Pu Fen Xi. 2016 May;36(5):1382-8
pubmed: 30001011
Nat Metab. 2022 May;4(5):524-533
pubmed: 35655024
Guang Pu Xue Yu Guang Pu Fen Xi. 2017 Jan;37(1):42-7
pubmed: 30192465
Biomed Opt Express. 2018 Jun 06;9(7):2917-2929
pubmed: 29984075
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Jan 15;265:120344
pubmed: 34481145
Talanta. 2022 Oct 1;248:123628
pubmed: 35660997
Food Chem. 2017 Jun 1;224:262-269
pubmed: 28159265
J Cell Mol Med. 2001 Oct-Dec;5(4):378-87
pubmed: 12067471
Sci Rep. 2017 Sep 22;7(1):12166
pubmed: 28939851
Atten Percept Psychophys. 2021 Jan;83(1):308-314
pubmed: 33098067
J Phys Chem A. 2012 Jun 7;116(22):5410-9
pubmed: 22624703